Navigation Links
Abbott Announces 10 Percent Increase in Quarterly Dividend
Date:2/19/2010

ABBOTT PARK, Ill., Feb. 19 /PRNewswire-FirstCall/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend 10 percent to 44 cents per share.

This marks the 38th consecutive year that Abbott has increased its dividend payout and the 345th consecutive quarterly dividend to be paid by Abbott since 1924.  The cash dividend is payable May 15, 2010, to shareholders of record at the close of business on April 15, 2010.

Abbott was recently named by Money as a leading dividend stock.  Additionally, Abbott is a top performer of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs approximately 83,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

SOURCE Abbott

Back to top

RELATED LINKS
http://www.abbott.com

'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott Completes Acquisition of Solvay Pharmaceuticals
2. Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
3. Abbott to Provide $1 Million in Funding, Products to Help Address Health Needs in Haiti
4. Feeding America and Abbott Transform Disaster Preparedness Into Hunger Relief
5. Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems
6. Abbott Declares 344th Consecutive Quarterly Dividend
7. Abbott Statement on ARBITER 6 - HALTS Results and Abbotts Niaspan (niacin extended-release)
8. Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
9. Abbott Receives Sustainability Award for Continued Efforts to Protect the Environment in Illinois
10. Abbott Again Honored for Offering One of the Top 10 Leading Workplaces
11. Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish to gain ... of a cosmetic procedure known as Carbon Dioxide (C02) Fractional Laser Resurfacing ... age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity or textural ...
(Date:12/2/2016)... ... December 02, 2016 , ... Halfway through its partnership with First 5 ... services to more than 15,900 children 5 years old and younger and treatment services ... over a span of five years to Western University of Health Sciences, UCLA and ...
(Date:12/2/2016)... Calif. (PRWEB) , ... December 02, 2016 , ... On ... at the Hard Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who ... neoplasms (MPNs) by going above and beyond the standard of care, demonstrating leadership within ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of travel therapy ... MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason ... extensive financial and operational leadership experience to Advanced Inc. He began his career in ...
(Date:12/2/2016)... ... 02, 2016 , ... The annual time frame to change Medicare health and ... ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current ... need to make changes during this period order for their new policy to go ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...  Former Attorney General of Louisiana , ... the law firm of Kahn Swick & Foti, LLC ("KSF"), ... Inc. (NYSE: LCI ). On ... "U.S. Charges in Generic-Drug Probe to Be Filed by Year-End," ... begun about two years ago, now spans more than a ...
(Date:12/4/2016)... , Dec. 3, 2016 Sickle cell disease ... sickle-shaped red blood cells that get stuck in veins ... stroke, organ failure, and complications leading to death. Each ... with SCD, and most of them lack access to ... only established long-term therapy for SCD, a pill called ...
(Date:12/4/2016)... A highly innovative, personalized cell-based treatment for a high-risk form of the ... from Children,s Hospital of Philadelphia today reported new ... (ALL). The physician-scientists presented findings at the annual meeting of ... . Continue Reading ... ...
Breaking Medicine Technology: